Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

People with Down syndrome carry an extra copy of chromosome 21. But it has been unclear which genes within this dense package of DNA are responsible for the disorder, which includes mental retardation, early onset Alzheimer’s disease and other health problems. In a paper published today in Nature Neuroscience, researchers identified two crucial genes, called Olig1 and Olig2, involved in Down syndrome. Reducing the activity of these genes in mice engineered to mimic the disorder helps correct abnormal brain activity in these animals, a problem that is also present in people with the disorder.

“We hope the findings will lead to better strategies for early intervention, even during the pregnancy, to reduce neurological consequences of Down syndrome,” said Zygmunt Galdzicki, associate professor of Anatomy, Physiology and Genetics at Uniformed Services University of the Health Sciences, in a statement from the university. “These findings show the need to do more human studies and also suggest that Olig1 and Olig2 inhibitors may have a potential therapeutic role for Down syndrome individuals.”

0 comments about this story. Start the discussion »

Tagged: Biomedicine, Down Syndrome, gene

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me